This study presents a comprehensive pan-cancer analysis of inflammatory age-clock-related genes (iAge-CRGs), revealing their genetic, epigenetic, and immunological alterations across 33 cancer types. It identifies DCBLD2 as a key regulator associated with poor prognosis and immune suppression, and establishes a five-gene prognostic signature for uveal melanoma.
CONTACT US
LOCATIONS
OUR VISION
To lead the fight against systemic chronic inflammation, creating a world where healthy living is the norm.
© EDIFICE Health, Inc. | All Rights Reserved